A natural sweetener found in the leaves of the Stevia plant may offer new hope for people struggling with hair loss.

Vamikibart is the first non-steroid targeted therapy designed to address inflammation driving UME and may offer a potential new treatment option for patientsVision improvements were seen in both ...

The automotive landscape is undergoing a monumental shift, and nowhere is this more evident than in the burgeoning market for ...

Positive results from the DESTINY-Breast11 Phase III trial showed ENHERTU ® (fam-trastuzumab deruxtecan-nxki) followed by paclitaxel, trastuzumab and pertuzumab (THP) in the neoadjuvant setting ...

Emerging clinical evidence supporting an immunomodulatory effect The use of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in clinical practice has increased as the multisystem benefits of this ...

Parnassus Mid Cap Growth Fund (Investor Shares) returned 7.90% (net of fees) for the quarter, outperforming the Russell Midcap Growth Index’s 2.78% return. Read more here.

Pimicotinib Treatment Demonstrates Deep and Durable Tumor Responses and Continued Improvements in Pain and Function for Patients with TGCT ...

Harbaji, W. and Abdulai, A. (2025) Factors Influencing Schoolchildren’s Obesity: A Qualitative Document Analysis of ...

This interesting study adapts machine learning tools to analyze movements of a chromatin locus in living cells in response to serum starvation. The machine learning approach developed is useful, the ...

CatalYm, a world-leader in neutralizing GDF-15 in cancer and cachexia, today presented compelling primary results from the Phase 2 GDFATHER-NEO trial in an oral late-breaking session at the European ...

Why is the quantum breakthrough in digital security important for your UPSC exam? What significance do topics such as the ...